Advertisement

Topics

ITBMed Raises $67M To Induce Organ Transplant Tolerance

22:56 EDT 5 Apr 2018 | SCRIP

Swedish biopharma ITBMed has secured $67m to develop siplizumab, its anti-CD2 monoclonal antibody, as an alternative to life-long use of...

      

Related Stories

 

Original Article: ITBMed Raises $67M To Induce Organ Transplant Tolerance

NEXT ARTICLE

More From BioPortfolio on "ITBMed Raises $67M To Induce Organ Transplant Tolerance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...